|
The innovation that comes with using artificial intelligence has the potential to bring incredible amounts of good to our lives, with the understanding that bad actors will and can take advantage of that. Senators Curtis and Blumenthal (D-CT) introduced the Quashing Unwanted and Interruptive Electronic Telecommunications (QUIET) Act, legislation that would require robocalls to notify consumers when artificial intelligence (AI) is being used in calls or messages. Almost all Americans have been affected by scams through robocalls and we must work to ensure that with new technology, we have new safeguards.
Read the full story by Eastin Hartzell here.
Utah is growing—and for good reason. People are drawn here by our strong economy, vibrant communities, and healthy environment. But with that growth comes challenges we must face head-on. Senators Curtis and Lee introduced bipartisan legislation to improve transit project timelines and quality by restoring the responsibility for environmental reviews back to state agencies from the federal government. The Streamline Transit Projects Act is cosponsored by Senators Kelly (D-AZ), and Warnock (D-GA) and endorsed by Utah Transit Authority, Wasatch Front Regional Council, and the American Public Transportation Association.
A recent survey by the Foundation for Individual Rights and Expression and College Pulse found that college students – especially UVU students – are apprehensive about public events. In response, Senator Curtis shared this brief message to Utah students:
Utah students deserve campuses where ideas are debated with both courage and respect.
Read the full story by Emma Pitts here.
So much of what is lost in our conversation about healthcare is the true cost associated with medications and medical devices. Senators Curtis and Rosen (D-NV) introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine.
|